ArticleFrontiers in pharmacology2023

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor

Iméne Ben Toumia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.